Evidence map›Paper›PMID 36544260›Full record

ArticleJournal of cachexia, sarcopenia and muscle2023

Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.

Julius Keyl, René Hosch, Aaron Berger, Oliver Ester, Tobias Greiner, Simon Bogner, Jürgen Treckmann, Saskia Ting, Brigitte Schumacher, David Albers and 7 more

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Julius KeylDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.ORCID 0000-0002-5617-091X
René HoschInstitute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.
Aaron BergerInstitute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.
Oliver EsterInstitute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.
Tobias GreinerMedical Faculty, University of Duisburg-Essen, Essen, Germany.
Simon BognerDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
Jürgen TreckmannDepartment of General, Visceral and Transplant Surgery, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
Saskia TingInstitute of Pathology Essen, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
Brigitte SchumacherDepartment of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
David AlbersDepartment of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
Peter MarkusDepartment of General Surgery and Traumatology, Elisabeth Hospital Essen, Essen, Germany.
Marcel WieswegDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
Michael ForstingDepartment of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen (AöR), Essen, Germany.
Felix NensaInstitute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.
Martin SchulerDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
Stefan KasperDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
Jens KleesiekInstitute for Artificial Intelligence in Medicine, University Hospital Essen (AöR), Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPersonalized therapy planning remains a significant challenge in advanced colorectal cancer care, despite extensive research on prognostic and predictive markers. A strong correlation of sarcopenia or overall body composition and survival has been described. Here, we explore whether automated assessment of body composition and liver metastases from standard of care CT images can add to clinical parameters in personalized survival risk prognostication.

methodsWe retrospectively analysed clinical imaging data from 85 patients (50.6% female, mean age 58.9 SD 12.2 years) with colorectal cancer and synchronous liver metastases. Pretrained deep learning models were used to assess body composition and liver metastasis geometry from abdominal CT images before the initiation of systemic treatment. Abdominal muscle-to-bone ratio (MBR) was calculated by dividing abdominal muscle volume by abdominal bone volume. MBR was compared with body mass index (BMI), abdominal muscle volume, and abdominal muscle volume divided by height squared. Differences in overall survival based on body composition and liver metastasis parameters were compared using Kaplan-Meier survival curves. Results were correlated with clinical and biomarker data to develop a machine learning model for survival risk prognostication.

resultsThe MBR, unlike abdominal muscle volume or BMI, was significantly associated with overall survival (HR 0.39, 95% CI: 0.19-0.80, P = 0.009). The MBR (P = 0.022), liver metastasis surface area (P = 0.01) and primary tumour sidedness (P = 0.007) were independently associated with overall survival in multivariate analysis. Body composition parameters did not correlate with KRAS mutational status or primary tumour sidedness. A prediction model based on MBR, liver metastasis surface area and primary tumour sidedness achieved a concordance index of 0.69.

conclusionsAutomated segmentation enables to extract prognostic parameters from routine imaging data for personalized survival modelling in advanced colorectal cancer patients.

Indexed as

Colorectal NeoplasmsDeep LearningLiver NeoplasmsBody CompositionFemaleHumansMaleMiddle AgedMuscle, SkeletalRetrospective StudiesTomography, X-Ray ComputedTumor BurdenBody compositionColorectal cancerComputed tomographyMachine learningPrognosis

Identifiers

PMID36544260
PMCPMC9891942

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.